Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
Definitive Healthcare announced the general availability of Passport Express, the newest product in the Passport Analytics Suite.
Definitive Healthcare announces timing of its second quarter 2022 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) announced that its second quarter ended June 30, 2022 financial results will be released on Thursday, August 4…
Definitive Healthcare launches Monocl ExpertInsight 2.0 and ExpertGO mobile app
Definitive Healthcare announces the availability of Monocl ExpertInsight 2.0 and a new mobile app ExpertGO
Definitive Healthcare to present at the Stifel 2022 Cross Sector Insight Conference
Definitive Healthcare’s Chief Executive Officer, its Chief Financial Officer, and its President, will present at the Stifel 2022 Cross Sector Insight…
Definitive Healthcare launches certification program and announces Apex Award winners at Definitive LIVE!
Definitive Healthcare (Nasdaq: DH) launches customer certification and announces winners of the Apex Award.
Definitive Healthcare to present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference
Definitive Healthcare (Nasdaq: DH) CEO Jason Krantz and CFO Rick Booth will present at J.P. Morgan Annual Global Technology, Media and Communications…
Definitive Healthcare reports financial results for first quarter 2022
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended March 31, 2022.
Definitive Healthcare names Robert Musslewhite as CEO effective August 1, 2022
Definitive Healthcare (Nasdaq: DH) announces Robert Musslewhite as the company’s next CEO, effective August 1, 2022.
Definitive Healthcare announces timing of its first quarter 2022 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) announces its first quarter results will be released on May 5, 2022 after market close.